Wellbutrin® Injury Lawyers

Wellbutrin®—also known as bupropion—is a prescription antidepressant that belongs to a class of drugs called norepinephrine-dopamine reuptake inhibitors (NDRIs). Unlike selective serotonin reuptake inhibitors, which increase serotonin levels, NDRIs work by increasing levels of dopamine in the brain.

In 2010, the American Journal of Obstetrics and Gynecology published a study linking the use of Wellbutrin by pregnant women to their children being born with serious congenital heart defects. If you took an NDRI while pregnant and your child was born with heart problems, the Wellbutrin injury lawyers at Ferrer, Poirot & Wansbrough are here to help you get the money you deserve. Just dial (800) 210-8503 or fill out a free initial consultation form.

Types of Wellbutrin® Heart Defects

Babies exposed to Wellbutrin while in the womb may develop heart defects, such as:

  • Hypoplastic Left Heart Syndrome
    This condition may cause the left side of a child’s heart to not fully develop, which can result in poor blood flow and enlargement of the right side of the heart. Open heart surgery is often required to treat this condition.
  • Coarctation of the Aorta
    This condition results in the narrowing of a child’s aorta, which can restrict blood flow to the limbs and lower parts of the body. Open heart surgery is often required to treat this condition.

Because Wellbutrin is defined as a Category C drug by the U.S. Food and Drug Administration, the drug manufacturer isn’t required to post warnings of the risk of birth defects. At Ferrer, Poirot & Wansbrough, we know that your child’s birth defects can be devastating, and we’ll fight for your rights to compensation for medical bills and other injury-related expenses.

The Ferrer, Poirot & Wansbrough Difference

The drug injury lawyers at our law firm help families around the country whose babies were born with birth defects because of medications. Now let us help you. Don’t wait to get the help you need—call us today.

Wellbutrin® is a registered trademark of GlaxoSmithKline.

This law firm is not associated with, sponsored by, or affiliated with the American Journal of Obstetrics & Gynecology, the U.S. Food and Drug Administration, or GlaxoSmithKline.